Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Urist Marshall
EVP, Research & Investments at Royalty Pharma. Filing since 20 May 2021.
CIK 0001838139
Company
Date
Role
Action
Shares
Amount
Of holding
RPRX
Royalty Pharma plc
5 Oct 2026
EVP, Research & Investments
Sold on a plan
4,126
$235.59K
100%
RPRX
Royalty Pharma plc
28 Sep 2026
EVP, Research & Investments
Sold on a plan
4,126
$238.81K
50.0%
RPRX
Royalty Pharma plc
1 Jul 2026
EVP, Research & Investments
Sold on a plan
9,099
$508.45K
100%
RPRX
Royalty Pharma plc
24 Jun 2026
EVP, Research & Investments
Sold on a plan
9,098
$502.07K
50.0%
RPRX
Royalty Pharma plc
20 May 2026
EVP, Research & Investments
Sold on a plan
13,684
$721.84K
42.9%
RPRX
Royalty Pharma plc
14 May 2026
EVP, Research & Investments
Sold on a plan
13,684
$726.14K
30.0%
RPRX
Royalty Pharma plc
30 Jan 2026
EVP, Research & Investments
Sold on a plan
20,000
$821.81K
100%
RPRX
Royalty Pharma plc
23 Jan 2026
EVP, Research & Investments
Sold on a plan
20,000
$805.11K
50.0%
RPRX
Royalty Pharma plc
16 Jan 2026
EVP, Research & Investments
Sold on a plan
20,000
$790.35K
33.3%
RPRX
Royalty Pharma plc
9 Jan 2026
EVP, Research & Investments
Sold on a plan
20,000
$815.63K
25.0%
RPRX
Royalty Pharma plc
2 Jan 2026
EVP, Research & Investments
Sold on a plan
20,000
$769.65K
20.0%
RPRX
Royalty Pharma plc
26 Dec 2025
EVP, Research & Investments
Sold on a plan
20,000
$786.38K
16.7%
RPRX
Royalty Pharma plc
19 Dec 2025
EVP, Research & Investments
Sold on a plan
20,000
$767.58K
14.3%
RPRX
Royalty Pharma plc
16 Dec 2025
EVP, Research & Investments
Sold on a plan
20,000
$766.42K
12.5%
RPRX
Royalty Pharma plc
5 Dec 2025
EVP, Research & Investments
Sold on a plan
23,334
$913.59K
12.7%
RPRX
Royalty Pharma plc
5 Dec 2025
EVP, Research & Investments
Sold on a plan
18,242
$714.22K
71.1%
RPRX
Royalty Pharma plc
1 Dec 2025
EVP, Research & Investments
Sold on a plan
23,333
$931.63K
11.3%
RPRX
Royalty Pharma plc
1 Dec 2025
EVP, Research & Investments
Sold on a plan
18,242
$727.86K
41.6%
RPRX
Royalty Pharma plc
22 Feb 2023
EVP, Research & Investments
Sold, plan not stated
23,333
$870.24K
33.3%
RPRX
Royalty Pharma plc
26 Jul 2022
EVP, Research & Investments
Sold, plan not stated
19,734
$852.46K
100%
RPRX
Royalty Pharma plc
25 Jul 2022
EVP, Research & Investments
Sold, plan not stated
3,600
$154.99K
15.4%
RPRX
Royalty Pharma plc
24 Jun 2022
EVP, Research & Investments
Sold, plan not stated
23,333
$1.01M
50.0%
RPRX
Royalty Pharma plc
16 May 2022
EVP, Research & Investments
Sold, plan not stated
23,333
$929.84K
33.3%
RPRX
Royalty Pharma plc
7 Jun 2021
EVP & Co-Head of R&I
Sold, plan not stated
16,568
$779.06K
100%
RPRX
Royalty Pharma plc
4 Jun 2021
EVP & Co-Head of R&I
Sold, plan not stated
16,566
$747.66K
50.0%
RPRX
Royalty Pharma plc
2 Jun 2021
EVP & Co-Head Research & Inv.
Sold, plan not stated
14,566
$604.85K
30.5%
RPRX
Royalty Pharma plc
21 May 2021
EVP & Co-Head Research & Inv.
Sold, plan not stated
100
$4.10K
0.2%
RPRX
Royalty Pharma plc
20 May 2021
EVP & Co-Head Research & Inv.
Sold, plan not stated
1,900
$78.06K
3.8%
28 decisions on file.
